Literature DB >> 3946921

Can thoracic gas volume be measured in infants with airways obstruction?

S Godfrey, C S Beardsmore, C Maayan, E Bar-Yishay.   

Abstract

Thoracic gas volume (Vtg) was measured in a whole-body, infant plethysmograph in 46 infants with recurrent wheezing after bronchiolitis, 25 infants with cystic fibrosis, and 6 infants without overt lung disease during the first 13 months of life. When related to weight or length, 56.5% of the bronchiolitic infants had low Vtg values, which were more than 2 SD below their predicted normal. The Vtg of the other groups was normal or above. The bronchiolitic infants with Vtg values in the normal range had more severe airways obstruction and it is probable that their Vtg values were also underestimated. Investigation of possible sources of technical or experimental error failed to reveal any explanation for the low Vtg in the bronchiolitic infants. In 5 infants, Vtg determined plethysmographically was correlated linearly to functional residual capacity determined by helium dilution, although Vtg values were greater in all. The administration of albuterol or treatment with steroids failed to make significant changes in Vtg in the bronchiolitic infants. It is suggested that there is a physiologic basis for the presumed underestimation of Vtg in wheezy infants after bronchiolitis, either because of uneven alveolar pressure changes within the chest leading to the effective exclusion of a portion of the lung volume or because there are some alveolar units with very low compliance that change little in volume during respiratory efforts against an occlusion. These results call into question the validity of the plethysmographic measurement of Vtg or airway resistance in these infants. If the error in Vtg is due to uneven alveolar pressure changes, it is suggested that the calculated specific airway conductance is probably correct.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946921     DOI: 10.1164/arrd.1986.133.2.245

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Echo planar imaging of an infant with pectus excavatum.

Authors:  C O'Callaghan; B Chapman; A Howseman; M Stehling; R Coxon; P Mansfield
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

Review 2.  Lung function testing in infancy.

Authors:  A D Milner
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 3.  Bronchiolitis and asthma in infancy and early childhood.

Authors:  S Godfrey
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

4.  Estimation of lung volume in infants by echo planar imaging and total body plethysmography.

Authors:  B Chapman; C O'Callaghan; R Coxon; P Glover; G Jaroszkiewicz; A Howseman; P Mansfield; P Small; A D Milner; R E Coupland
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

5.  Disturbance in respiratory mechanics in infants with bronchiolitis.

Authors:  S Godfrey
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

6.  Do lung volumes change with sleep state in the neonate?

Authors:  G M Stokes; A D Milner; E A Newball; N J Smith; C Dunn; A J Wilson
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

7.  Disturbance in respiratory mechanics in infants with bronchiolitis.

Authors:  J Seidenberg; I B Masters; I Hudson; A Olinsky; P D Phelan
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

8.  Bronchial responsiveness to histamine in wheezy infants.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

9.  Dose-response relationships and time course of the response to systemic beta adrenoreceptor agonists in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; M H Schöni
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

Review 10.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.